AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CLINUVEL PHARMACEUTICALS LTD

8.020

-0.450-5.31%

Volume:332.58K

Turnover:2.71M

Market Cap:402.61M

PE:12.01

High:8.570

Open:8.470

Low:8.010

Close:8.470

52wk High:13.480

52wk Low:8.010

Shares:50.20M

Float Shares:41.32M

Volume Ratio:1.35

T/O Rate:0.80%

Dividend:0.05

Dividend Rate:0.62%

EPS(TTM):0.668

EPS(LYR):0.718

ROE:13.21%

ROA:8.94%

PB:1.48

PE(LYR):11.17

Loading ...

Overview Company News Filings

Company Profile

Company Name:

CLINUVEL PHARMACEUTICALS LTD

Exchange:

ASX

Establishment Date:

1999

Employees:

16

Office Location:

535 Bourke Street,Level 22,Melbourne,Victoria,Australia

Website:

http://www.clinuvel.com

Zip Code:

3000

Phone:

Fax:

61 3 9660 4999

Introduction:

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of severe genetic and skin disorders in Europe, the United States, and Singapore. Its lead drug candidate is SCENESSE, a photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria. The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; and VLRX001, an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited for launching SCENESSE under a named patient program for the treatment of patients with erythropoietic protoporphyria in the People's Republic of China. The company was incorporated in 1999 and is headquartered in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/CUV.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CUV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","market":"AU","secType":"STK","nameCN":"CLINUVEL PHARMACEUTICALS LTD","latestPrice":8.02,"timestamp":1788156720000,"preClose":8.47,"halted":0,"volume":332582,"delay":0,"changeRate":-0.05312868949232598,"nameEN":"CLINUVEL PHARMACEUTICALS LTD","floatShares":41318955,"shares":50200740,"eps":0.667999,"marketStatus":"Not Yet Opened","change":-0.45,"latestTime":"08-31 16:12:00 AEST","open":8.47,"high":8.57,"low":8.01,"amount":2707448,"amplitude":0.066116,"askPrice":8.18,"askSize":128,"bidPrice":8.01,"bidSize":2889,"shortable":3,"etf":0,"ttmEps":0.667999,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":8.47,"dividendRate":0.006234,"openAndCloseTimeList":[[1788134400000,1788156000000]],"volumeRatio":1.34668,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CUV.AU","preClose":8.47,"auctionPrice":8.02,"auctionVolume":17546,"auction":3,"marketStatus":"盘后竞价","timestamp":1788156605868}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","floatShares":41318955,"roa":"8.94%","roe":"13.21%","lyrEps":0.717999,"volumeRatio":1.34668,"shares":50200740,"dividePrice":0.05,"high":8.57,"amplitude":0.066116,"preClose":8.47,"low":8.01,"week52Low":8.01,"pbRate":"1.48","psRate":"4.28","week52High":13.48,"institutionHeld":0,"latestPrice":8.02,"committee":0.915147,"eps":0.667999,"divideRate":0.006234,"volume":332582,"delay":0,"ttmEps":0.667999,"open":8.47,"prevYearClose":12.46,"prevWeekClose":8.47,"prevMonthClose":9.06,"prevQuarterClose":10.28,"fiveDayClose":10.32,"twentyDayClose":9.16,"sixtyDayClose":9.13,"dividendPayoutRate":0.07372445631899688,"dividendFrequency":"A","dividendGrowthYears":6,"dividendGrowthRate":0,"fiveYearAvgDividendRate":0.003390100329748879},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUV.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-03","symbol":"CUV.AU","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-04","defaultRemindTime":1788393600000,"name":"CLINUVEL PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-04","currency":"AUD","dateTimestamp":1788357600000,"payDate":"2026-09-18"},{"date":"2026-08-27","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787788800000,"name":null,"time":"","dateTimestamp":1787752800000,"actualEps":null},{"date":"2026-02-26","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772060400000,"name":null,"time":"","dateTimestamp":1772024400000,"actualEps":null},{"date":"2025-09-04","symbol":"CUV.AU","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-05","defaultRemindTime":1756944000000,"name":"CLINUVEL PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-05","currency":"AUD","dateTimestamp":1756908000000,"payDate":"2025-09-19"},{"date":"2025-08-28","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756339200000,"name":null,"time":"","dateTimestamp":1756303200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUV.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-03","recordDate":"2020-09-04","paymentDate":"2020-09-18","value":0.025,"currency":"AUD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-17","value":0.025,"currency":"AUD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-09-21","value":0.04,"currency":"AUD"},{"executeDate":"2023-09-05","recordDate":"2023-09-06","paymentDate":"2023-09-20","value":0.05,"currency":"AUD"},{"executeDate":"2024-09-05","recordDate":"2024-09-06","paymentDate":"2024-09-20","value":0.05,"currency":"AUD"}],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":6117181,"yearFounded":1999,"employeeNum":16,"address":"535 Bourke Street,Level 22,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9660 4900","officeFax":"61 3 9660 4999","fiscalYearEnd":"06-30"},"stockCompanyDetail":{"websiteUrl":"http://www.clinuvel.com","stockEarnings":[{"period":"1week","weight":-0.2229},{"period":"1month","weight":-0.1148},{"period":"3month","weight":-0.1089},{"period":"6month","weight":-0.1655},{"period":"1year","weight":-0.2433},{"period":"ytd","weight":-0.3563}],"compareEarnings":[{"period":"1week","weight":-0.0084},{"period":"1month","weight":-0.0142},{"period":"3month","weight":0.0607},{"period":"6month","weight":0.0479},{"period":"1year","weight":0.1042},{"period":"ytd","weight":0.048}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of severe genetic and skin disorders in Europe, the United States, and Singapore. Its lead drug candidate is SCENESSE, a photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria. The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; and VLRX001, an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited for launching SCENESSE under a named patient program for the treatment of patients with erythropoietic protoporphyria in the People's Republic of China. The company was incorporated in 1999 and is headquartered in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.36,"avgChangeRate":-0.039665},{"month":2,"riseRate":0.538462,"avgChangeRate":0.007441},{"month":3,"riseRate":0.5,"avgChangeRate":0.009444},{"month":4,"riseRate":0.538462,"avgChangeRate":0.047574},{"month":5,"riseRate":0.269231,"avgChangeRate":-0.045296},{"month":6,"riseRate":0.576923,"avgChangeRate":0.060851},{"month":7,"riseRate":0.576923,"avgChangeRate":0.051868},{"month":8,"riseRate":0.48,"avgChangeRate":-0.004565},{"month":9,"riseRate":0.52,"avgChangeRate":0.020713},{"month":10,"riseRate":0.44,"avgChangeRate":0.036647},{"month":11,"riseRate":0.52,"avgChangeRate":0.025676},{"month":12,"riseRate":0.56,"avgChangeRate":0.063246}],"exchange":"ASX","name":"CLINUVEL PHARMACEUTICALS LTD","nameEN":"CLINUVEL PHARMACEUTICALS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CUV.AU\",market:\"AU\",,,undefined,":null}}